Regular consumption of spinach helps prevent Alzheimer’s disease

Ulm University researchers conducted a comparative study of 74 patients with mild Alzheimer’s disease and 158 healthy participants. Participants were between 65 and 90 years old. They underwent a neuropsychological test, answered multiple questions about their lifestyle, conducted blood tests, and measured body mass index. It was found that there was a correlation between low vitamin and β-carotene levels and Alzheimer’s disease. Therefore, vegetables and fruits rich in antioxidants such as spinach, carrots and apricots help to alleviate the symptoms of Alzheimer’s disease.

The head of the new research, the epidemiologist Professor Gabriel Nagel and the neurologist Professor Christine Anim found that antioxidant vitamins in patients with Alzheimer’s disease compared with healthy participants in the control group. The serum concentrations of C and β-carotene were significantly lower. However, there were no such differences in the levels of other antioxidants such as vitamin E, lycopene and coenzyme Q10 in the two groups.

Dr. Nagel said that although the results of this new study need more longitudinal studies to confirm, new research shows that fruits and vegetables can play an important role in fighting Alzheimer’s disease. Citrus fruits are rich in vitamin C, and carrots, spinach or apricots are rich in beta-carotene.

Scientists say that symptoms of Alzheimer’s disease include: forgetfulness, lack of direction and cognitive decline. Direct causes include: accumulation of substances such as β-amyloid in the brain, aging of nerve cells in the brain; neurofibrillary degeneration and loss of synapses Wait. However, oxidative stress not only inhibits the body’s use of oxygen, but also accelerates the progression of Alzheimer’s disease. To this end, German scientists have launched “the feasibility study of antioxidants to prevent neurodegeneration (nerve degeneration).”

The new study was funded by the Ministry of Science and Technology of Baden-Württemberg, Germany, and the new findings were published in the latest issue of the Journal of Alzheimer’s Disease.